These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27086703)

  • 1. Exercise-induced neuroprotective effects on neurodegenerative diseases: the key role of trophic factors.
    Campos C; Rocha NB; Lattari E; Paes F; Nardi AE; Machado S
    Expert Rev Neurother; 2016 Jun; 16(6):723-34. PubMed ID: 27086703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of physical exercise on plasma brain-derived neurotrophic factor in neurodegenerative disorders: A systematic review and meta-analysis of randomized controlled trials.
    Ruiz-González D; Hernández-Martínez A; Valenzuela PL; Morales JS; Soriano-Maldonado A
    Neurosci Biobehav Rev; 2021 Sep; 128():394-405. PubMed ID: 34087277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurotrophic factors: basis for their clinical application].
    Morís G; Vega JA
    Neurologia; 2003; 18(1):18-28. PubMed ID: 12590377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 2: Where do we stand and where must we go next?
    Bartus RT; Johnson EM
    Neurobiol Dis; 2017 Jan; 97(Pt B):169-178. PubMed ID: 27063797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical tests of neurotrophic factors for human neurodegenerative diseases, part 1: Where have we been and what have we learned?
    Bartus RT; Johnson EM
    Neurobiol Dis; 2017 Jan; 97(Pt B):156-168. PubMed ID: 27063798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nerve growth factor in neurodegeneration and neurorestorative therapy].
    Lorigados-Pedre L; Bergado-Rosado J
    Rev Neurol; 2004 May 16-31; 38(10):957-71. PubMed ID: 15175980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases.
    Duarte-Neves J; Pereira de Almeida L; Cavadas C
    Neurobiol Dis; 2016 Nov; 95():210-24. PubMed ID: 27461050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of insulin-like growth factor I signaling in neurodegenerative diseases.
    Trejo JL; Carro E; Garcia-Galloway E; Torres-Aleman I
    J Mol Med (Berl); 2004 Mar; 82(3):156-62. PubMed ID: 14647921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of trophic factors and inflammatory processes in physical activity-induced neuroprotection in Parkinson's disease.
    Pałasz E; Bąk A; Gąsiorowska A; Niewiadomska G
    Postepy Hig Med Dosw (Online); 2017 Jan; 71(1):713-726. PubMed ID: 28894046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and neurorestorative activities of a novel iron chelator-brain selective monoamine oxidase-A/monoamine oxidase-B inhibitor in animal models of Parkinson's disease and aging.
    Bar-Am O; Amit T; Kupershmidt L; Aluf Y; Mechlovich D; Kabha H; Danovitch L; Zurawski VR; Youdim MB; Weinreb O
    Neurobiol Aging; 2015 Mar; 36(3):1529-42. PubMed ID: 25499799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.
    Wang Q; Yan J; Chen X; Li J; Yang Y; Weng J; Deng C; Yenari MA
    Exp Neurol; 2011 Jul; 230(1):27-34. PubMed ID: 20406638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic factor therapy for Parkinson's disease.
    Rangasamy SB; Soderstrom K; Bakay RA; Kordower JH
    Prog Brain Res; 2010; 184():237-64. PubMed ID: 20887879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. We need to move more: Neurobiological hypotheses of physical exercise as a treatment for Parkinson's disease.
    Monteiro-Junior RS; Cevada T; Oliveira BR; Lattari E; Portugal EM; Carvalho A; Deslandes AC
    Med Hypotheses; 2015 Nov; 85(5):537-41. PubMed ID: 26209418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repairing the parkinsonian brain with neurotrophic factors.
    Aron L; Klein R
    Trends Neurosci; 2011 Feb; 34(2):88-100. PubMed ID: 21144600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases.
    Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S
    Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective effect of focused ultrasound: New perspectives on an old tool.
    Yulug B; Hanoglu L; Kilic E
    Brain Res Bull; 2017 May; 131():199-206. PubMed ID: 28458041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
    Chen JF; Chern Y
    Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases.
    Weinreb O; Mandel S; Amit T; Youdim MB
    J Nutr Biochem; 2004 Sep; 15(9):506-16. PubMed ID: 15350981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies.
    Fernandez-Espejo E
    Mol Neurobiol; 2004 Feb; 29(1):15-30. PubMed ID: 15034220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders.
    Mattson MP; Maudsley S; Martin B
    Trends Neurosci; 2004 Oct; 27(10):589-94. PubMed ID: 15374669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.